LSV Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.97M | Sell |
2,750,200
-1,247,601
| -31% | -$895K | ﹤0.01% | 557 |
|
|
2025
Q1 | $5.88M | Sell |
3,997,801
-83,700
| -2% | -$123K | 0.01% | 460 |
|
|
2024
Q4 | $18.1M | Sell |
4,081,501
-970,100
| -19% | -$4.3M | 0.04% | 329 |
|
|
2024
Q3 | $20.8M | Sell |
5,051,601
-1,019,900
| -17% | -$4.2M | 0.04% | 312 |
|
|
2024
Q2 | $39.6M | Sell |
6,071,501
-79,500
| -1% | -$518K | 0.09% | 237 |
|
|
2024
Q1 | $53.6M | Sell |
6,151,001
-631,100
| -9% | -$5.5M | 0.11% | 210 |
|
|
2023
Q4 | $77.6M | Sell |
6,782,101
-382,108
| -5% | -$4.37M | 0.17% | 172 |
|
|
2023
Q3 | $69M | Sell |
7,164,209
-506,100
| -7% | -$4.87M | 0.16% | 177 |
|
|
2023
Q2 | $81.6M | Buy |
7,670,309
+92,600
| +1% | +$985K | 0.18% | 168 |
|
|
2023
Q1 | $79.7M | Sell |
7,577,709
-348,688
| -4% | -$3.67M | 0.18% | 163 |
|
|
2022
Q4 | $98.2M | Buy |
7,926,397
+12,177
| +0.2% | +$151K | 0.22% | 145 |
|
|
2022
Q3 | $82M | Buy |
7,914,220
+435,063
| +6% | +$4.51M | 0.19% | 153 |
|
|
2022
Q2 | $86.2M | Buy |
7,479,157
+71,827
| +1% | +$828K | 0.19% | 157 |
|
|
2022
Q1 | $93.2M | Sell |
7,407,330
-100,076
| -1% | -$1.26M | 0.17% | 161 |
|
|
2021
Q4 | $87.5M | Sell |
7,507,406
-304,821
| -4% | -$3.55M | 0.16% | 171 |
|
|
2021
Q3 | $102M | Buy |
7,812,227
+3,448,000
| +79% | +$45M | 0.18% | 155 |
|
|
2021
Q2 | $56.2M | Buy |
4,364,227
+3,390,228
| +348% | +$43.6M | 0.1% | 221 |
|
|
2021
Q1 | $10.9M | Buy |
+973,999
| New | +$10.9M | 0.02% | 454 |
|